CervoMed Inc. Marketable Securities, Unrealized Gain (Loss)
CervoMed Inc. (CRVO) reported Marketable Securities, Unrealized Gain (Loss) of -$5.71 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-07
- CervoMed Inc. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was $314.00.
- CervoMed Inc. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was -$6.02K.
- CervoMed Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-06-30 was -$22.01K, a 211.69% decline year-over-year.
- CervoMed Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-03-31 was -$34.97K.
- CervoMed Inc. marketable securities, unrealized gain (loss) for fiscal 2024 was $56.20K.
- CervoMed Inc. marketable securities, unrealized gain (loss) for fiscal 2023 was $0.00.
- CervoMed Inc. marketable securities, unrealized gain (loss) for fiscal 2022 was -$35.38K.
- CervoMed Inc. marketable securities, unrealized gain (loss) for fiscal 2021 was $0.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 3 month as first filed | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 6 month as first filed | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $314.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$5.71K 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | -$6.02K 10-Q · filed 2026-05-15 | |||||
| 2025-06-30 | -$22.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$56.98K 10-Q · filed 2026-08-07 | ||||
| 2025-03-31 | -$34.97K 10-Q · filed 2026-05-15 | |||||
| 2024-12-31 | $56.20K 10-K · filed 2025-03-17 | |||||
| 2024-06-30 | $19.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $19.70K 10-Q · filed 2025-08-08 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | |||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 | |||||
| 2023-06-30 | $32.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $51.58K derived: sum of 3 quarters · filed 2024-08-09 | -$121.96K derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | -$32.25K 10-Q · filed 2023-05-15 | $19.33K derived: sum of 2 quarters · filed 2023-05-15 | -$154.21K derived: sum of 3 quarters · filed 2023-05-15 | -$117.28K derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-12-31 | $51.58K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$121.96K derived: sum of 2 quarters · filed 2023-03-24 | -$85.03K derived: sum of 3 quarters · filed 2023-08-08 | -$35.38K 10-K · filed 2023-03-24 | ||
| 2022-09-30 | -$173.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$136.61K derived: sum of 2 quarters · filed 2023-08-08 | -$86.95K 10-Q · filed 2022-11-14 | -$86.95K derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-06-30 | $36.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $86.58K 10-Q · filed 2023-08-08 | -$86.58K 10-Q · filed 2022-08-12 | $86.58K derived: sum of 3 quarters · filed 2023-08-08 | $86.58K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $49.66K 10-Q · filed 2023-05-15 | -$49.66K 10-Q · filed 2022-05-12 | $49.66K derived: sum of 2 quarters · filed 2023-05-15 | $49.66K derived: sum of 3 quarters · filed 2023-05-15 | $49.66K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $0.00 derived: sum of 2 quarters · filed 2023-03-24 | $0.00 derived: sum of 3 quarters · filed 2023-03-24 | $0.00 10-K · filed 2023-03-24 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |